Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,994 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not yet recruiting

A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)

NCT05181501

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First People's Hospital of Changzhou Changzhou, Jiangsu, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Not yet recruiting

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

NCT05054465

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Soroka Medical Center Beersheba, Israel
  • Rambam Health Care Campus Haifa, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
  • Rabin Medical Center Petah Tikva, Israel
View Trial Details
Not yet recruiting

Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL

NCT04913103

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Hradec Králové Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View Trial Details

Related conditions